Pope Francis is eating and intravenous feeding has never been mentioned, the Vatican said as he continues to battle pneumonia ...

Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in ...

After patients had undergone a 3-week run-in of subcutaneous darbepoetin alfa, they were randomized 1:1 to receive either subcutaneous or intravenous darbepoetin alfa once a week for 20 weeks ...

The following is a summary of “Discarded intravenous medication in the ICU: the GAME-OVER multicenter prospective observational study,” published in the February 2025 issue of Critical Care by ...

Researchers from Revolo Biotherapeutics Ltd. recently presented preclinical data for IRL-201104, a clinical-stage ...

Switching from established intravenous (IV) therapy to subcutaneous infliximab was associated with high treatment persistence, stable clinical disease activity, and consistent faecal calprotectin ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge ...

our study was limited by low power to detect an effect in a small but clinically important fraction of patients receiving the combination of high-dose intravenous calcium and concurrent ceftriaxone.

The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...

The new formulation of Keytruda, currently under FDA review, is sparking conflict with Halozyme, which makes enzymes that ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...